---
$id: https://graph.org.ai/products/commodity/51201816
$type: Product
source: UNSPSC
code: "51201816"
title: "Impromidine"
class: "51201800"
classTitle: "Immunostimulating agents"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Impromidine

**UNSPSC Code**: 51201816
**Class**: [Immunostimulating agents](Immunostimulating agents.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-lipidemic agent with the molecular formula C14H23N7S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 931L4X5WMM, chemically known as guanidine, n-(3-(1h-imidazol-4-yl)propyl)-n-(2-(((5-methyl-1h-imidazol-4-yl)methyl)thio)ethyl)- but generally known as impromidine, which bears US NIH Compound Identifier 41376. European Medicines Agency schedules Impromidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08159MIG. The term IMPROMIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). IMPROMIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule impromidine under HS 29332990 and SITC 51573. As of Q4 2014, IMPROMIDINE remains the US FDA Preferred Term for this commodity. Impromidine bears US NLM identifiers UMLS ID C0063440 and NCI Concept Code C65902. SMILES: S(CCN/C(=N/CCCC1[NH]CNC1)N)CC1NC[NH]C1C.

